OPKO Health, Inc. Operating Leases, Rent Expense
OPKO Health, Inc. (OPK) reported Operating Leases, Rent Expense of $18.90 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-03-01
- OPKO Health, Inc. operating leases, rent expense for fiscal 2018 was $18.90M, a 0.00% change from fiscal 2017.
- OPKO Health, Inc. operating leases, rent expense for fiscal 2017 was $18.90M, a 0.53% increase from fiscal 2016.
- OPKO Health, Inc. operating leases, rent expense for fiscal 2016 was $18.80M.
- OPKO Health, Inc. operating leases, rent expense for fiscal 2014 was $2.60M, a 36.84% increase from fiscal 2013.
| Period end | Operating Leases, Rent Expense 12 month |
|---|---|
| 2018-12-31 | $18.90M 10-K · filed 2019-03-01 |
| 2017-12-31 | $18.90M 10-K · filed 2019-03-01 |
| 2016-12-31 | $18.80M 10-K · filed 2019-03-01 |
| 2015-12-31 | $7.80M 8-K · filed 2019-01-29 |
| 2014-12-31 | $2.60M 10-K · filed 2017-03-01 |
| 2013-12-31 | $1.90M 10-K · filed 2016-02-29 |
| 2012-12-31 | $1.30M 10-K · filed 2015-02-27 |
| 2011-12-31 | $700.00K 10-K · filed 2014-03-03 |
| 2010-12-31 | $800.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |